Federal govment don set up National Task Force on Clinical governance and Patient Safety to make health system strong, stop ...

US developer's chief executive Kyle Clark explains why hitting 100,000nm flown has offered critical lessons as the company ...

Another leak surfaced, offering alleged details about an Android 16 feature to help users manage device intrusions.

The tech giant released iOS 26.3 (a) to beta users, marking the debut of their new “Background Security Improvements” system ...

Existing treatments for other conditions show potential for use in managing type 1 diabetes, a recent scientific conference heard ...

New Telehealth Model Combines Weekly Therapy with Daily Professional Coaching, Allowing Clients to Maintain Work and ...

Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes. Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage ...

Hims & Hers trades at FWD EV/Sales of 3.45x and FWD EV/EBITDA of 25.85x, with FY2030 targets implying further upside for ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

Tesla’s Full Self Driving program has entered a strange new phase, where the software is improving quickly, the business ...

FDA approval of mitapivat signals a shift in thalassaemia care, offering the first oral option to treat chronic anaemia.